Elēkrŏn Ventures
Overview
Elēkrŏn Ventures is a venture capital firm that invests in opportunities intended to create an impact in any potential sector, with a higher interest in early-stage investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CORE Biomedicine | Jul 2026 | Series A | Lead |
| Oricell Therapeutics | Apr 2026 | Growth Equity | Co-investor |
| Angitia Biopharmaceuticals | Feb 2026 | Series D | Co-investor |
For institutional investors. Book with your work email.
Key People
Wees Abraham
Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Elēkrŏn Ventures based?
Elēkrŏn Ventures is headquartered in Dubai, United Arab Emirates.
When was Elēkrŏn Ventures founded?
Elēkrŏn Ventures was founded in 2016.
How many portfolio companies does Elēkrŏn Ventures have?
Elēkrŏn Ventures has 4 portfolio companies in Caplight's dataset.
What are some companies in Elēkrŏn Ventures's portfolio?
Portfolio companies visible on Caplight include CORE Biomedicine, Oricell Therapeutics, Angitia Biopharmaceuticals.
What was Elēkrŏn Ventures's most recent investment shown here?
Elēkrŏn Ventures's most recent investment in this portfolio sample was in CORE Biomedicine in 2026.
What sectors does Elēkrŏn Ventures focus on?
Elēkrŏn Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Real Estate & PropTech.
What company stages does Elēkrŏn Ventures focus on?
Elēkrŏn Ventures typically invests at the Late stage.
What is Elēkrŏn Ventures's AUM?
Elēkrŏn Ventures's assets under management are estimated between $50.0M and $50.0M.